Detalhe da pesquisa
1.
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma.
N Engl J Med
; 389(21): 1961-1971, 2023 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870920
2.
Current Status of Predictive Biomarker Development in Metastatic Renal Cell Carcinoma.
Curr Oncol Rep
; 25(6): 671-677, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37000341
3.
Current Understanding of Urachal Adenocarcinoma and Management Strategy.
Curr Oncol Rep
; 22(1): 9, 2020 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31989430
4.
A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study).
Ther Adv Med Oncol
; 16: 17588359231217958, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38264520
5.
A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03).
Tumori
; 109(1): 129-137, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36447337
6.
Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study.
EClinicalMedicine
; 61: 102044, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37434748
7.
Biomarker-driven immunotherapy for precision medicine in prostate cancer.
Per Med
; 19(1): 51-66, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34873959
8.
Optimal Choice of Adjuvant Treatment for Renal Cell Carcinoma Following Nephrectomy.
Cancer Manag Res
; 14: 3071-3081, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36275783
9.
Update on radioligand therapy with 177Lu-PSMA for metastatic castration-resistant prostate cancer: clinical aspects and survival effects.
Tumori
; 108(4): 315-325, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34405748
10.
Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma: Results of the BONSAI Trial for the Italian Network for Research in Urologic-Oncology (Meet-URO 2 Study).
JAMA Oncol
; 8(6): 910-913, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35420628
11.
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21).
Expert Rev Anticancer Ther
; 22(1): 115-121, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34738499
12.
Low dose of ketoconazole in patients with prostate adenocarcinoma resistant to pharmacological castration.
BJU Int
; 108(2): 223-7, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21078047
13.
Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases.
BJU Int
; 108(8 Pt 2): E250-7, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21599821
14.
Third-line chemotherapy with tyrosine kinase inhibitor (imatinib mesylate) in recurrent ovarian granulosa cell tumor: case report.
J Obstet Gynaecol Res
; 37(12): 1864-7, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21955167
15.
Second-line treatment in renal cell carcinoma: clinical experience and decision making.
Ther Adv Urol
; 13: 17562872211022870, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34211586
16.
Characteristics and Treatment Challenges of Non-Clear Cell Renal Cell Carcinoma.
Cancers (Basel)
; 13(15)2021 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34359706
17.
Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio.
Front Immunol
; 12: 697298, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34858389
18.
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2).
J Immunother Cancer
; 9(5)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34016723
19.
Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer.
Front Oncol
; 10: 1644, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32903369
20.
The emerging role of PARP inhibitors in prostate cancer.
Expert Rev Anticancer Ther
; 20(8): 715-726, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32758032